Literature DB >> 6632719

[Clinical picture and prognosis of generalized mastocytosis].

H P Horny, M R Parwaresch, K Lennert.   

Abstract

Proliferation of tissue mast cells in more than one organ is a rare disease, called generalized mastocytosis. Findings obtained in 35 cases were compared with 125 case reports in order to elucidate the course of the disease and its clinical picture. The results indicated that generalized mastocytosis has to be divided into two variants, designated systemic mastocytosis and malignant mastocytosis. Systemic mastocytosis is characterized by urticaria pigmentosa-like skin eruptions, with simultaneous infiltration of at least one visceral organ (usually bone marrow). Other frequently involved organs are spleen, liver, and lymph nodes. The age curve is biphasic, with one peak in early childhood and another in the 6th decade. The prognosis of systemic mastocytosis is generally favorable (actuarial survival 0.88 one year after diagnosis). In contrast to systemic mastocytosis, malignant mastocytosis does not show urticaria pigmentosa-like skin lesions. In this variant of generalized mastocytosis, frequently involved organs are bone marrow, spleen, liver, and lymph nodes. Common symptoms are anemia and eosinophilia. The age curve shows a peak in later life (6th and 7th decades). Malignant mastocytosis is never seen in children.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1983        PMID: 6632719     DOI: 10.1007/BF01496722

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  14 in total

1.  [ON THE SELECTIVE ENZYME-CYTOCHEMICAL DEMONSTRATION OF NEUTROPHILIC MYELOID CELLS AND TISSUE MAST CELLS IN PARAFFIN SECTIONS].

Authors:  L D LEDER
Journal:  Klin Wochenschr       Date:  1964-06-01

2.  [Studies on acid mucopolysaccharides in the tissue mast cells of human bone marrow].

Authors:  K LENNERT; J C SCHUBERT
Journal:  Frankf Z Pathol       Date:  1959

3.  Urticaria pigmentosa with systemic lesions and otosclerosis.

Authors:  M R LERNER; A B LERNER
Journal:  Arch Dermatol       Date:  1960-02

4.  Tissue mast cell leukemia.

Authors:  B I FRIEDMAN; J J WILL; D G FREIMAN; H BRAUNSTEIN
Journal:  Blood       Date:  1958-01       Impact factor: 22.113

5.  Histamine in tissue mast cells.

Authors:  J F RILEY
Journal:  Science       Date:  1953-09-18       Impact factor: 47.728

6.  Urticaria pigmentosa; a report of a case with autopsy.

Authors:  J M ELLIS
Journal:  Arch Pathol (Chic)       Date:  1949-11

7.  Histamine release from human leukocytes by anti-gamma E antibodies.

Authors:  T Ishizaka; K Ishizaka; S G Johansson; H Bennich
Journal:  J Immunol       Date:  1969-04       Impact factor: 5.422

8.  Portal hypertension associated with systemic mastocytosis and splenomegaly.

Authors:  S Grundfest; A M Cooperman; R Ferguson; S Benjamin
Journal:  Gastroenterology       Date:  1980-02       Impact factor: 22.682

9.  Portal hypertension in systemic mastocytosis.

Authors:  J E Bredfeldt
Journal:  Gastroenterology       Date:  1980-09       Impact factor: 22.682

10.  [Peroxidase deficiency in neutrophils in systemic mastocytosis (author's transl)].

Authors:  F Turpin; F Lejeune; J L Vilde; D Le Coq; P Lotholary; A Paraf
Journal:  Nouv Rev Fr Hematol       Date:  1978-04-14
View more
  2 in total

1.  Mast cell sarcoma of the larynx.

Authors:  H P Horny; M R Parwaresch; E Kaiserling; K Müller; M Olbermann; K Mainzer; K Lennert
Journal:  J Clin Pathol       Date:  1986-06       Impact factor: 3.411

2.  Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.

Authors:  K Sotlar; T Marafioti; H Griesser; J Theil; C Aepinus; R Jaussi; H Stein; P Valent; H P Horny
Journal:  Mol Pathol       Date:  2000-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.